Compare compounds
Choose up to three compounds and compare target, format, purity and certificate of analysis side by side.
Retatrutide vs Tirzepatide

- Research area
- Weight-loss and metabolism research
- Receptor target
- Triple agonist: GLP-1, GIP and glucagon receptors
- Presentation
- Pre-filled multi-dose pen · 2/4/8 mg setting
- Strength
- 32 mg
- HPLC purity
- 98.75%
- Certificate (CoA)
- Published: see the batch report
- Studied alongside
- Tirzepatide

- Research area
- Weight-loss and metabolism research
- Receptor target
- Dual agonist: GLP-1 and GIP receptors
- Presentation
- Pre-filled multi-dose pen
- Strength
- 60 mg
- HPLC purity
- 99.27%
- Certificate (CoA)
- Published: see the batch report
- Studied alongside
- Retatrutide
Supplied strictly for research and analytical purposes. Not for human consumption and not medical advice. The data above describe the material as delivered; purity comes from the published certificate of analysis (CoA) of the current batch.
Body Pharm against other suppliers
Data-based comparisons between the Body Pharm catalogue and other research peptide suppliers in Spain and Europe: format, amount of active compound, price per milligram, certificate of analysis and delivery, side by side. Research use only.